- Prevalence and Clinical Associations of Lupus Anticoagulant, Anticardiolipin Antibodies, and Anti-beta2-glycoprotein I Antibodies in Patients with Systemic Lupus Erythematosus
-
Woo KS, Kim KE, Kim JM, Han JY, Chung WT, Kim KH
- KMID: 1096817
- Korean J Lab Med.
- 2010 Feb;30(1):38-44.
- doi: 10.3343/kjlm.2010.30.1.38
BACKGROUND: The presence of antiphospholipid antibodies (aPLs) is associated with the clinical features of antiphospholipid syndrome (APS), which comprises venous and arterial thrombosis and pregnancy loss, and systemic lupus erythematosus... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Implications of Elevated Antiphospholipid Antibodies in Adult Patients with Primary Immune Thrombocytopenia
-
Yang YJ, Yun GW, Song IC, Baek SW, Lee KS, Ryu HW, Lee MW, Lee HJ, Yun HJ, Kim S, Jo DY
- KMID: 1729248
- Korean J Intern Med.
- 2011 Dec;26(4):449-454.
- doi: 10.3904/kjim.2011.26.4.449
BACKGROUND/AIMS: Antiphospholipid antibodies (aPL) have been detected in various proportions of patients with primary immune thrombocytopenia (ITP), but the clinical significance of this is debatable. The present study aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Silica Clotting Time for Detection of Lupus Anticoagulants
-
Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI
- KMID: 1781601
- Korean J Lab Med.
- 2009 Dec;29(6):497-504.
- doi: 10.3343/kjlm.2009.29.6.497
BACKGROUND: The presence of lupus anticoagulants (LA) is a strong risk factor for thrombosis in antiphospholipid syndrome. We investigated the usefulness of addition of silica clotting time (SCT) to the... -
- CITED
-
- Close
- SHARE
-
- Close
